Home>>Analytical Standards>>Heptadecanoic Acid-d3

Heptadecanoic Acid-d3 (Synonyms: C17:0-d3, Heptadecylic Acid-d3, Margaric Acid-d3)

Catalog No.GC47422

An internal standard for the quantification of heptadecanoicacid

Products are for research use only. Not for human use. We do not sell to patients.

Heptadecanoic Acid-d3 Chemical Structure

Cas No.: 202528-95-8

Size Price Stock Qty
1 mg
$43.00
In stock
5 mg
$194.00
In stock
10 mg
$342.00
In stock
25 mg
$750.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Heptadecanoic acid-d3 is intended for use as an internal standard for the quantification of heptadecanoic acid by GC- or LC-MS. Heptadecanoic acid is an odd-chain saturated fatty acid that contains seventeen carbons and has been found in milk fat.1 Heptadecanoic acid has been used as an internal standard for the quantification of fatty acids in human plasma by LC- and GC-MS and as a biomarker for dairy fat intake.1,2

1.Jenkins, B., West, J.A., and Koulman, A.A review of odd-chain fatty acid metabolism and the role of pentadecanoic acid (c15:0) and heptadecanoic acid (c17:0) in health and diseaseMolecules20(2)2425-2444(2015) 2.Yakoob, M.Y., Shi, P., Hu, F.B., et al.Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohortsAm. J. Clin. Nutr.100(6)1437-1447(2014)

Reviews

Review for Heptadecanoic Acid-d3

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Heptadecanoic Acid-d3

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.